These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 1794133
1. Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden. Olsson H, Borg A, Fernö M, Möller TR, Ranstam J. Cancer Detect Prev; 1991; 15(4):265-71. PubMed ID: 1794133 [Abstract] [Full Text] [Related]
2. Early oral contraceptive use as a prognostic factor in breast cancer. Olsson H, Möller TR, Ranstam J, Borg A, Fernö M. Anticancer Res; 1988; 8(1):29-32. PubMed ID: 3358638 [Abstract] [Full Text] [Related]
3. Weighing the evidence on the pill and breast cancer. Johnson JH. Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859 [Abstract] [Full Text] [Related]
4. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age. Olsson H, Lindahl B, Ranstam J, Borg A, Fernö M, Norgren A. Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773 [Abstract] [Full Text] [Related]
5. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD. Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436 [Abstract] [Full Text] [Related]
6. Survival in breast cancer and age at start of oral contraceptive usage. Ranstam J, Olsson H, Garne JP, Aspegren K, Janzon L. Anticancer Res; 1991 May; 11(6):2043-6. PubMed ID: 1776838 [Abstract] [Full Text] [Related]
7. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE. Acta Endocrinol (Copenh); 1991 May; 125 Suppl 1():13-26. PubMed ID: 1801500 [Abstract] [Full Text] [Related]
8. Researchers can now investigate long-term effects of OCs on cancer. Rubin GL, Peterson HB. Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918 [Abstract] [Full Text] [Related]
9. At pill's 30th birthday, breast cancer question is unresolved. Althaus FA, Kaeser L. Fam Plann Perspect; 1990 Jan; 22(4):173-6. PubMed ID: 2226748 [Abstract] [Full Text] [Related]
10. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Kay CR. Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858 [Abstract] [Full Text] [Related]
13. Oral contraceptive use and the risk of breast cancer in young women. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1984 Jun 29; 33(25):353-4. PubMed ID: 6427584 [Abstract] [Full Text] [Related]
16. Breast cancer epidemiology. Kelsey JL, Berkowitz GS. Cancer Res; 1988 Oct 15; 48(20):5615-23. PubMed ID: 3048646 [Abstract] [Full Text] [Related]
17. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy). Tzingounis V, Cardamakis E, Ginopoulos P, Argiropoulos G. Anticancer Res; 1996 Oct 15; 16(6C):3997-4000. PubMed ID: 9042326 [Abstract] [Full Text] [Related]
19. Combined progestin and estrogen (oral), and other forms of hormonal contraception. McPherson K. Curr Opin Obstet Gynecol; 1991 Aug 15; 3(4):486-90. PubMed ID: 1878505 [Abstract] [Full Text] [Related]